Seeking Alpha

  InterMune, Inc. (ITMN) - NASDAQ

  • MyHappyTrading | Send Message 5 Mar 2010

    $ITMN up more than +60% on drug review!
    Reply
      ITMN vs. ETF Alternatives
      Company Description
      InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States